Anacor Pharmaceuticals - Articles and news items

anacor

Pfizer completes acquisition of Anacor Pharmaceuticals

Industry news / 27 June 2016 / Victoria White, Digital Content Producer

The Anacor acquisition adds crisaborole, a differentiated non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, to Pfizer’s pipeline…

Anacor’s crisaborole achieves primary and secondary endpoints in two Phase 3 studies in eczema

Industry news / 13 July 2015 / Victoria White

Anacor has announced positive preliminary top-line results from its two Phase 3 pivotal studies of crisaborole in atopic dermatitis (eczema)…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+